Table of Content

1 Scope of the Report
1.1 Market Introduction
1.1 Prostate Cancer Diagnostics and Therapy Introduction
1.2 Research Purposes
1.3 Report Timeline
2 Prostate Cancer Diagnostics and Therapy Market Overview
2.1 World Market Overview
2.1.1 Global Prostate Cancer Diagnostics and Therapy Market Size & Forecast 2017-2028
2.1.2 Prostate Cancer Diagnostics and Therapy Market Size CAGR by Region
2.2 Prostate Cancer Diagnostics and Therapy Market Analysis by Type
2.3 Prostate Cancer Diagnostics and Therapy Market Size Analysis by Type
2.3.1 Global Prostate Cancer Diagnostics and Therapy Market Size Market Share Analysis by Type (2017-2022)
2.3.2 Global Prostate Cancer Diagnostics and Therapy Value and Market Share Analysis by Type (2017-2022)
2.4 Prostate Cancer Diagnostics and Therapy Market Analysis by Applications
2.5 Prostate Cancer Diagnostics and Therapy Market Size Analysis by Application
2.5.1 Global Prostate Cancer Diagnostics and Therapy Market Size Analysis by Application (2017-2022)
2.5.2 Global Prostate Cancer Diagnostics and Therapy Market Share Analysis by Application (2017-2022)
3 Key Players Analysis
3.1 Ipsen SA
3.1.1 Company Profiles
3.1.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.2 Pfizer Inc.
3.2.1 Company Profiles
3.2.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.3 Johnson & Johnson Services Inc.
3.3.1 Company Profiles
3.3.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.4 Bayer AG
3.4.1 Company Profiles
3.4.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.5 Abbvie Inc.
3.5.1 Company Profiles
3.5.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.6 Merck & Co. Inc.
3.6.1 Company Profiles
3.6.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.7 AstraZeneca PLC
3.7.1 Company Profiles
3.7.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.8 Thermo Fisher Scientific
3.8.1 Company Profiles
3.8.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.9 Dendreon Pharmaceuticals LLC
3.9.1 Company Profiles
3.9.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.10 F. Hoffmann-La Roche Ltd
3.10.1 Company Profiles
3.10.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.11 Hologic Inc.
3.11.1 Company Profiles
3.11.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.12 Astellas Pharma Inc.
3.12.1 Company Profiles
3.12.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.13 Koninklijke Philips NV
3.13.1 Company Profiles
3.13.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
3.14 Sanofi-Aventis
3.14.1 Company Profiles
3.14.2 Prostate Cancer Diagnostics and Therapy Product Introduction
3.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Value, Gross, Gross Margin 2017-2022
4 Global Prostate Cancer Diagnostics and Therapy Historical and Forecast Market Analysis by Types
4.1 Prostate Cancer Diagnostics and Therapy Market Analysis by Types 2017-2022
4.2 Prostate Cancer Diagnostics and Therapy Market Analysis by Types 2023-2028
5 Global Prostate Cancer Diagnostics and Therapy Historical and Forecast Market Analysis by Applications
5.1 Prostate Cancer Diagnostics and Therapy Market Analysis by Applications 2017-2022
5.2 Prostate Cancer Diagnostics and Therapy Market Analysis by Applications 2023-2028
6 North America Prostate Cancer Diagnostics and Therapy Market Analysis
6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
6.2 Prostate Cancer Diagnostics and Therapy Key Players in North America (2020-2021)
6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
6.4 North America Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
7 Europe Prostate Cancer Diagnostics and Therapy Market Analysis
7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
7.2 Prostate Cancer Diagnostics and Therapy Key Players in Europe (2020-2021)
7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
7.4 Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
8 China Prostate Cancer Diagnostics and Therapy Market Analysis
8.1 China Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
8.2 Prostate Cancer Diagnostics and Therapy Key Players in China (2020-2021)
8.3 China Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
8.4 China Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
9 Japan Prostate Cancer Diagnostics and Therapy Market Analysis
9.1 Japan Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
9.2 Prostate Cancer Diagnostics and Therapy Key Players in Japan (2020-2021)
9.3 Japan Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
9.4 Japan Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
10 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Analysis
10.1 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
10.2 Prostate Cancer Diagnostics and Therapy Key Players in Southeast Asia (2020-2021)
10.3 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
10.4 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
11 India Prostate Cancer Diagnostics and Therapy Market Analysis
11.1 India Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
11.2 Prostate Cancer Diagnostics and Therapy Key Players in India (2020-2021)
11.3 India Prostate Cancer Diagnostics and Therapy Market Size by Type (2017-2028)
11.4 India Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2028)
12 Prostate Cancer Diagnostics and Therapy Market Dynamics
12.1 Market Drivers
12.2 Market Restraints
12.3 Opportunity
12.4 Market Trends
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.2.3 Legal Disclaimer